Table 1 Characteristics of the study population
Category | No. (%) | p-value | ||
|---|---|---|---|---|
t (n = 53) | c (n = 29) | i (n = 24) | ||
Gender | ||||
Female n (%) | 19 (35.8) | 12 (41.4) | 7 (29.2) | 0,40a |
Male n (%) | 34 (64.2) | 17 (58.6) | 17 (70.8) | |
Age | ||||
Mean (SD) | 46.51 (12.0) | 46.93 (12.7) | 46.0 (11.4) | 0,78b |
Median (25%; 75%) | 48.0 (37.5; 56.0) | 48.0 (40.5; 57.5) | 48.5 (36.5; 54.0) | |
Self-reported BSA | ||||
Mean (SD) | 8.56 (17.56) | 10.25 (20.27) | 6.67 (14.1) | 0,83c |
Median (25%; 75%) | 2.5 (1.0; 5.0) | 2.0 (0.3; 9.0) | 2.8 (1.3; 5.0) | |
DLQI | ||||
Mean (SD) | 6.38 (6.93) | 6.28 (7.58) | 6.50 (6.22) | 0,55c |
Median (25%; 75%) | 4.0 (1.0; 9.0) | 4.0 (1.0; 7.5) | 5.0 (1.25; 10.0) | |
Disease duration | ||||
Mean (SD) | 18.13 (12.76) | 19.29 (12.38) | 16.79 (13.34) | 0,49b |
Median (25%; 75%) | 15.0 (9.0; 26.5) | 18.0 (9.0; 27.0) | 12.0 (7.5; 20.0) | |
BMI | ||||
Mean (SD) | 29.05 (6.27) | 28.32 (6.54) | 29.92 (5.95) | 0,10c |
Median (25%; 75%) | 27.4 (24.5; 32.1) | 25.3 (23.8; 32.4) | 28.4 (26.1; 32.5) | |
Comorbidity | ||||
Psoriatic arthritis, n (%) | 18 (34) | 10 (34.5) | 8 (33.3) | 1,00a |
Depression, n (%) | 11 (21.2) | 7 (24.1) | 4 (17.4) | 0,73a |
Allergy, n (%) | 17 (32.7) | 11 (37.9) | 6 (26.1) | 0,39a |
Hypertension n (%) | 19 (36.5) | 10 (34.5) | 9 (39.1) | 0,78a |
Cardiovascular diseases, n (%) | 3 (5.8) | 2 (6.9) | 1 (5.5) | 1,00a |
Hypercholesterolemia, n (%) | 11 (21.2) | 5 (17.2) | 6 (26.1) | 0,51a |
COPD, asthma, n (%) | 9 (17.3) | 7 (24.1) | 2 (8.7) | 0,27a |
Hepatitis, cirrhosis of the liver, other liver diseases, n (%) | 3 (5.8) | 3 (10.3) | 0 | 0,25a |
Diabetes mellitus, n (%) | 5 (9.6) | 2 (6.9) | 3 (13) | 0,64a |
Cancer, n (%) | 1 (1.9) | 0 | 1 (5.5) | 0,44a |
No comorbidities, n (%) | 14 (26.9) | 8 (27.6) | 6 (26.1) | 1,00a |
Current smoker, n (%) | 20 (39.2) | 11 (39.3) | 9 (39.1) | 1,00a |
Ex-smoker, n (%) | 16 (31.4) | 7 (25) | 9 (39.1) | 0,37a |
Non-smoker, n (%) | 15 (29.4) | 10 (35.7) | 5 (21.7) | 0,36a |